Your AI-Trained Oncology Knowledge Connection!
Two medical oncologists from Florida Cancer Specialists & Research Institute participated in the Florida Society of Clinical Oncology Fellow & Resident Educational Training Program. The program featured respected keynote speakers to share helpful information for transitioning into the oncology workforce.
Florida Cancer Specialists & Research Institute launched a new website to host a variety of top articles ranging from recent oncology and hematology studies to new therapies, even topics on value-based care.
Margarett Ellison, MD, gynecologic oncologist with Gynecologic Oncology of Tallahassee, A Division of Florida Cancer Specialists & Research Institute, has been designated as a National GYN Oncology Observation Site for Intuitive Surgical.
Florida Cancer Specialists and Research Institute welcomed Ken Sturtz, MBA, MHA to its executive leadership team as Chief Information Officer.
Joshua Eaves joined the Florida Cancer Specialists & Research Institute senior management team as senior vice president, corporate development.
Skill, passion and teamwork. Essential elements for patient centered partnerships.
The survival rate for Americans diagnosed with several of the most common cancers has increased dramatically in the past nearly three decades, thanks in large part to scientific discoveries and treatment advances.
Florida Cancer Specialists Nurse Receives Inaugural MBC Heroes™ Award from CURE Media Group.
Florida Cancer Specialists & Research Institute, in collaboration with AdventHealth Heart of Florida and Central Florida Cancer Institute, has received a three-year accreditation from the National Accreditation Program for Breast Centers, a quality program of the American College of Surgeons.
Three medical oncologists at Florida Cancer Specialists & Research Institute are co-authors on a new integrated safety analysis of umbralisib, used to treat lymphoid malignancies.
Michael Diaz, MD will assume the role of President & Managing Physician at Florida Cancer Specialists & Research Institute.
Since 2016, Florida Cancer Specialists & Research Institute has been a national leader in the transition of oncology care from a fee-for-service reimbursement structure to fee-for-value.
A survey of more than 6,800 cancer patients conducted this month by Florida Cancer Specialists & Research Institute found that patients overwhelmingly prefer that the FCS physicians, nurses and staff members who provide their care are vaccinated and wear masks to reduce the spread of COVID-19 and provide a safe environment within clinics.
